Eden
No verdict has been issued yet.
This is a neutral factual record. Eden (tryeden.com, also eden.health) is a direct-to-consumer telehealth membership platform operated by Eden Health International Inc., which the FDA's June 2026 warning letter and Eden's BBB profile both list at 110 16th St Ste 1431, Denver, CO 80202; Eden's Terms of Service separately list a Wilmington, Delaware address, consistent with a registered-agent filing address rather than an operating office. Eden sells compounded semaglutide ($99/mo) and compounded tirzepatide ($199/mo), plus brand-name Ozempic, Wegovy, Zepbound, and Mounjaro at list price (roughly $1,399-$1,695/mo), all gated behind a required $39-first-month/$99-per-month-thereafter membership. On the specific lead this record was built to verify: multiple third-party affiliate/review sites (healingmaps.com, therxindex.com, and others) report that Eden "paused its compounded GLP-1 program for new patient enrollment as of mid-2026." That claim is NOT supported by a direct check of Eden's own live site on the access date below - as of 2026-07-12, tryeden.com's own homepage banner reads "Compounded semaglutide for $99/mo, free expedited shipping on all orders," the eden.health/weight-loss page actively lists both compounded semaglutide and compounded tirzepatide with working "Get started" checkout links, and Eden's own intake flow (app.eden.health/intake/weightloss/welcome) is live and accepting new-patient intake with no waitlist, closed-enrollment, or paused-program notice anywhere in the page. One of the affiliate sources making the pause claim (therxindex.com) also uses the same page to steer readers toward a competitor ("the closest replacement we'd check next is Embody") - a pattern consistent with affiliate-marketing content rather than a verified operational fact. It is possible the reports reflect a temporary pause that has since lifted, or confusion with Eden's June 8, 2026 FDA warning letter, but no primary source (news outlet, regulator, or Eden's own site) was located that documents an actual enrollment pause; the balance of direct evidence indicates the compounded GLP-1 program is currently open to new patients. Eden's own About page names four fulfillment pharmacies (GoGoMeds, Precision, Enovex, AbsolutePharmacy) and states its combined pharmacy/provider network serves all 50 states and DC. Eden received an FDA warning letter (June 8, 2026, MARCS-CMS 728279) for website claims that made Eden appear to be the compounder of its own semaglutide/tirzepatide products and for describing its compounding sources as "FDA-licensed 503(a) outsourcing facilities" (a designation the FDA says does not exist) - a concern signal about labeling/marketing accuracy, not a shutdown order. Eden also carries an F rating and BBB Pattern-of-Complaints alert with 102 filed complaints and no response to 78 of them. Founding date and any parent company beyond Eden Health International Inc. itself are not disclosed in the sources reviewed. No news coverage of a lawsuit or state attorney-general action specific to Eden's GLP-1 business was located as of the access date.
The supply chain
What checks out
What to watch
- Score
- 4.5 / 5 across 2,726 reviews (trailing 12 months)
- Review source
- 88% organic (unprompted) · 12% verified or invited (company-sent, post-transaction)OrganicVerified / invited
88% of this company's Trustpilot reviews are organic (unprompted), above our 40% threshold. Verified and invited reviews both require a real completed transaction and the company choosing to send the invite, which makes them hard to fabricate at scale. A heavy skew toward organic, unprompted reviews is a known review-manipulation vector — it does not by itself disqualify a clinic, but it weighs against the verdict. See how we weigh this.
- Legal entity
- Eden Health International Inc.
- Listed address
- c/o Firstbase Agent LLC, 1007 N Orange St, 4th Fl, Ste 2985, Wilmington, DE 19801
- Notes
- The only notice address the company gives is explicitly its registered agent's Wilmington mail suite; no operational street address is published.
Who fills your prescription
Eden is a multi-vertical telehealth membership platform operated by Eden Health International Inc. Per Eden's own site, it does not compound medication itself: a "Partner pharmacy information" disclosure on its About page names four independent pharmacies that fill prescriptions for its patients, and states that "Eden's pharmacies and provider network offer service to all 50 states and Washington, D.C." Eden's Terms of Service do not name any pharmacy - they refer only generically to a "Pharmacy Network" - so the About-page disclosure is the only place the fulfilling pharmacies are named. Separately, Eden also operates its own in-house compounding pharmacy, branded "Eden Pharmacy" (formerly Contigo Compounding, acquired by Eden), based in Albuquerque, NM and licensed in 25 states (sterile and non-sterile compounding in most, non-sterile only in Florida and Massachusetts per Eden Pharmacy's own site); Eden's public disclosures do not state whether Eden Pharmacy itself fills any of the GLP-1 prescriptions sold under the tryeden.com/eden.health brand, or whether it serves other verticals only, so that relationship is recorded as not disclosed rather than assumed.
Partner pharmacies have not yet been profiled. Each named partner must clear the pharmacy gate independently before this clinic stays on the index.
What it's actually like
Pricing and membership (per eden.health/weight-loss and tryeden.com): compounded semaglutide is listed at $99/mo and compounded tirzepatide at $199/mo, both marked "price includes medication only, if prescribed." Brand-name Ozempic, Zepbound, and Mounjaro are each listed at $1,399/mo and Wegovy at $1,695/mo. All of it requires an active "Eden Membership": $39 for the first month, auto-renewing at $99/month thereafter; the site states plainly that "membership does not include or guarantee a prescription" and "medication is not available without a membership." Product mix: beyond GLP-1s, Eden's own site lists medications with active ingredients semaglutide, tirzepatide, liraglutide, setmelanotide, phentermine, orlistat, and naltrexone-bupropion as items a licensed provider may consider, plus off-label antidepressant use in certain cases - and separately markets sermorelin, NAD+, hair-growth, and hormone-therapy verticals under the same Eden brand and membership. Intake: a "quick form" reviewed by "a licensed medical provider 100% online," described as same-day; the live intake flow (app.eden.health/intake/weightloss/welcome, checked 2026-07-12) opens with a weight-loss-goal question and proceeds through a standard health-history questionnaire, with no waitlist or paused-enrollment messaging observed. Pharmacy chain: per a "Partner pharmacy information" section on Eden's own About page, "Eden utilizes a network of pharmacies including GoGoMeds, Precision, Enovex, and AbsolutePharmacy," each with a listed address (see pharmacyPartnerNames), and "together, Eden's pharmacies and provider network offer service to all 50 states and Washington, D.C." Eden's Terms of Service, by contrast, only refer generically to "the Providers and Pharmacy Network you access through the Services," without naming any pharmacy - the naming exists only on the About page. Eden separately operates (or has acquired) its own compounding pharmacy under the "Eden Pharmacy" brand (previously Contigo Compounding), based in Albuquerque, NM and stated to be "licensed and operates in 25 states," with sterile and non-sterile compounding in most of those states and non-sterile-only in Florida and Massachusetts; nothing in the sources reviewed states whether Eden Pharmacy fulfills any of the GLP-1 prescriptions described above. Refund/cancellation/refill: the $39 first-month membership fee is refunded only if no prescription is issued after intake; membership fees are otherwise non-refundable once a billing cycle starts; medication orders are stated as "non-refundable, in whole or in part, once the order has been fulfilled"; cancellation requires 48 hours' notice before the next renewal date. Governing law: Delaware, with mandatory binding arbitration and a class-action waiver; non-arbitrable disputes go to state or federal courts in Wilmington, Delaware. A separate Eden referral/rewards program explicitly excludes Florida residents from eligibility - a narrower carve-out than a statement about general service availability, and distinct from the 50-states-and-DC claim on the About page. Regulatory history: FDA's Center for Drug Evaluation and Research issued a warning letter to "Eden Health International Inc. dba Eden" on June 8, 2026 (MARCS-CMS 728279), following a March 2026 review of tryeden.com, alleging the site's product images labeled compounded semaglutide and tirzepatide with Eden's own name in a way that implied Eden itself compounds the drugs (it does not), and that the site falsely described its compounding sources as "FDA-licensed 503(a) outsourcing facilities" - a designation FDA says does not exist for any compounding pharmacy or outsourcing facility. FDA gave Eden 15 business days to respond with the identity of the entities that actually produce its compounded products, sample labeling, and confirmation that the false claims were corrected or removed. Consumer-complaint record: Eden's BBB profile (Denver, CO; file opened 4/4/2024) carries an F rating, is not BBB-accredited, lists 102 complaints filed against the business with no response to 78 of them, and carries a BBB "Pattern of Complaints" alert. A Trustpilot profile for tryeden.com exists (confirmed via search-result listings only, not a direct fetch, since Trustpilot returns 403 to automated access); third-party search snippets describe an approximate 4-star average across several thousand reviews, a figure not independently verified here and recorded only as a search-snippet observation.
Eden in your state
Ship-to coverage per our record, and the state-by-state read: whether Eden's partner pharmacies hold a license where you live, checked against each state board's own portal. Click any state for its file.
How we review. Every clinic must clear two gates: a credible compounding pharmacy, licensed in every state it ships to, and a clinic that supports long-term patient success. We pay for our own access and accept no payment, referral fees, or coupon arrangements from anyone we cover. See the methodology.